| 1 |
Thai AA，Solomon BJ，Sequist LV，et al.Lung cancer［J］.Lancet，2021，398（10299）：535-554.
|
| 2 |
Molina JR，Yang P，Cassivi SD，et al.Non-small cell lung cancer：epidemiology，risk factors，treatment，and survivorship［J］.Mayo Clin Proc，2008，83（5）：584-594.
|
| 3 |
Chen Z，Fillmore CM，Hammerman PS，et al.Non-smallcell lung cancers：a heterogeneous set of diseases［J］.Nat Rev Cancer，2014，14（8）：535-546.
|
| 4 |
Derynck R，Turley SJ，Akhurst RJ.TGFβ biology in cancer progression and immunotherapy［J］.Nat Rev Clin Oncol，2021，18（1）：9-34.
|
| 5 |
Xia L，Oyang L，Lin J，et al.The cancer metabolic reprogramming and immune response［J］.Mol Cancer，2021，20（1）：28.
|
| 6 |
Bagaev A，Kotlov N，Nomie K，et al.Conserved pan-cancer microenvironment subtypes predict response to immunotherapy［J］.Cancer Cell，2021，39（6）：845-865.e7.
|
| 7 |
Paget S.The distribution of secondary growths in cancer of the breast.1889［J］.Cancer Metastasis Rev，1989，8（2）：98-101.
|
| 8 |
Laplane L，Duluc D，Bikfalvi A，et al.Beyond the tumour microenvironment［J］.Int J Cancer，2019，145（10）：2611-2618.
|
| 9 |
Khosravi N，Caetano MS，Cumpian AM，et al.IL22 Promotes Kras-Mutant Lung Cancer by Induction of a Protumor Immune Response and Protection of Stemness Properties［J］.Cancer Immunol Res，2018，6（7）：788-797.
|
| 10 |
Dhainaut M，Rose SA，Akturk G，et al.Spatial CRISPR genomics identifies regulators of the tumor microenvironment［J］.Cell，2022，185（7）：1223-1239.e20.
|
| 11 |
Liu J，Ren L，Li S，et al.The biology， function， and applications of exosomes in cancer［J］.Acta Pharm Sin B，2021，11（9）：2783-2797.
|
| 12 |
Piersma B，Hayward MK，Weaver VM.Fibrosis and cancer：A strained relationship［J］.Biochim Biophys Acta Rev Cancer，2020，1873（2）：188356.
|
| 13 |
Bigos KJ，Quiles CG，Lunj S，et al.Tumour response to hypoxia：understanding the hypoxic tumour microenvironment to improve treatment outcome in solid tumours［J］.Front Oncol，2024，14：1331355.
|
| 14 |
Kalluri R.The biology and function of fibroblasts in cancer［J］.Nat Rev Cancer，2016，16（9）：582-598.
|
| 15 |
Duan H，Liu Y，Gao Z，et al.Recent advances in drug delivery systems for targeting cancer stem cells［J］.Acta Pharm Sin B，2021，11（1）：55-70.
|
| 16 |
Jain S，Rick JW，Joshi RS，et al.Single-cell RNA sequencing and spatial transcriptomics reveal cancer-associated fibroblasts in glioblastoma with protumoral effects［J］.J Clin Invest，2023.
|
| 17 |
Wu F，Yang J，Liu J，et al.Signaling pathways in cancerassociated fibroblasts and targeted therapy for cancer［J］.Signal Transduct Target Ther，2021，6（1）：218.
|
| 18 |
Costa A，Kieffer Y，Scholer-Dahirel A，et al.Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer［J］.Cancer Cell，2018，33（3）：463-479.e10.
|
| 19 |
Rimal R，Desai P，Daware R，et al.Cancer-associated fibroblasts：Origin，function，imaging，and therapeutic targeting［J］.Adv Drug Deliv Rev，2022，189：114504.
|
| 20 |
Huang H，Wang Z，Zhang Y，et al.Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer［J］.Cancer Cell，2022，40（6）：656-673.e7.
|
| 21 |
Tao Z，Huang C，Wang D，et al.Lactate induced mesenchymal stem cells activation promotes gastric cancer cells migration and proliferation［J］.Exp Cell Res，2023，424（1）：113492.
|
| 22 |
Kundu M，Butti R，Panda VK，et al.Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer［J］.Mol Cancer，2024，23（1）：92.
|
| 23 |
Cho H，Kim JH，Jun CD，et al.CAF-Derived IL6 and GM-CSF Cooperate to Induce M2-like TAMs-Response［J］.Clin Cancer Res，2019，25（2）：894-895.
|
| 24 |
Radomska KJ，Coulpier F，Gresset A，et al.Cellular Origin，Tumor Progression，and Pathogenic Mechanisms of Cutaneous Neurofibromas Revealed by Mice with Nf1 Knockout in Boundary Cap Cells［J］.Cancer Discov，2019，9（1）：130-147.
|
| 25 |
Yang M，Li J，Gu P，et al.The application of nanoparticles in cancer immunotherapy：Targeting tumor microenvironment［J］.Bioact Mater，2021，6（7）：1973-1987.
|
| 26 |
Farhood B，Najafi M，Mortezaee K.CD8（+）cytotoxic T lymphocytes in cancer immunotherapy：A review［J］.J Cell Physiol，2019，234（6）：8509-8521.
|
| 27 |
Niu N，Shen X，Wang Z，et al.Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer［J］.Cancer Cell，2024，42（5）：869-884.e9.
|
| 28 |
Jenkins BH，Tracy I，Rodrigues MFSD，et al.Single cell and spatial analysis of immune-hot and immune-cold tumours identifies fibroblast subtypes associated with distinct immunological niches and positive immunotherapy response［J］.Mol Cancer，2025，24（1）：3.
|
| 29 |
Huang B，Chen Q，Ye Z，et al.Construction of a Matrix Cancer-Associated Fibroblast Signature Gene-Based Risk Prognostic Signature for Directing Immunotherapy in Patients with Breast Cancer Using Single-Cell Analysis and Machine Learning［J］.Int J Mol Sci，2023，24（17）：13175.
|
| 30 |
Song J，Wei R，Liu C，et al.Antigen-presenting cancer associated fibroblasts enhance antitumor immunity and predict immunotherapy response［J］.Nat Commun，2025，16（1）：2175.
|
| 31 |
Niu Z，Chen C，Wang S，et al.HBO1 catalyzes lysine lactylation and mediates histone H3K9la to regulate gene transcription［J］.Nat Commun，2024，15（1）：3561.
|
| 32 |
Coursier D，Calvo F.CAFs vs. TECs：when blood feuds fuel cancer progression， dissemination and therapeutic resistance［J］.Cell Oncol（Dordr），2024，47（4）：1091-1112.
|
| 33 |
Mezawa Y，Orimo A.Phenotypic heterogeneity， stability and plasticity in tumor-promoting carcinoma-associated fibroblasts［J］.FEBS J，2022，289（9）：2429-2447.
|
| 34 |
Kim DK，Jeong J，Lee DS，et al.PD-L1-directed PlGF/VEGF blockade synergizes with chemotherapy by targeting CD141（+）cancer-associated fibroblasts in pancreatic cancer［J］.Nat Commun，2022，13（1）：6292.
|
| 35 |
Liu B，Zhang B，Qi J，et al.Targeting MFGE8 secreted by cancer-associated fibroblasts blocks angiogenesis and metastasis in esophageal squamous cell carcinoma［J］.Proc Natl Acad Sci U S A，2023，120（42）：e2307914120.
|
| 36 |
Broz MT，Ko EY，Ishaya K，et al.Metabolic targeting of cancer associated fibroblasts overcomes T-cell exclusion and chemoresistance in soft-tissue sarcomas［J］.Nat Commun，2024，15（1）：2498.
|
| 37 |
Ling J，Chiao PJ.Two Birds with One Stone：Therapeutic Targeting of IL1α Signaling Pathways in Pancreatic Ductal Adenocarcinoma and the Cancer-Associated Fibroblasts［J］.Cancer Discov，2019，9（2）：173-175.
|
| 38 |
Garcia Garcia CJ，Huang Y，Fuentes NR，et al.Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer Microenvironment［J］.Gastroenterology，2022，162（7）：2018-2031.
|
| 39 |
Liu Z，Hayashi H，Matsumura K，et al.Hyperglycaemia induces metabolic reprogramming into a glycolytic phenotype and promotes epithelial-mesenchymal transitions via YAP/TAZHedgehog signalling axis in pancreatic cancer［J］.Br J Cancer，2023，128（5）：844-856.
|
| 40 |
Sahai E，Astsaturov I，Cukierman E，et al.A framework for advancing our understanding of cancer-associated fibroblasts［J］.Nat Rev Cancer，2020，20（3）：174-186.
|
| 41 |
Grout JA，Sirven P，Leader AM，et al.Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T-cell Exclusion in Human Lung Tumors［J］.Cancer Discov，2022，12（11）：2606-2625.
|
| 42 |
Tsoumakidou M.The advent of immune stimulating CAFs in cancer［J］.Nat Rev Cancer，2023，23（4）：258-269.
|
| 43 |
Zhang Y，Fang Z，Pan D，et al.Dendritic Polymer-Based Nanomedicines Remodel the Tumor Stroma：Improve Drug Penetration and Enhance Antitumor Immune Response［J］.Adv Mater，2024，36（25）：e2401304.
|
| 44 |
Chen X，Song E.Turning foes to friends：targeting cancer-associated fibroblasts［J］.Nat Rev Drug Discov，2019，18（2）：99-115.
|
| 45 |
Liu Y，Xun Z，Ma K，et al.Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy［J］.J Hepatol，2023，78（4）：770-782.
|
| 46 |
Zhang H，Yue X，Chen Z，et al.Define cancer-associated fibroblasts （CAFs） in the tumor microenvironment：new opportunities in cancer immunotherapy and advances in clinical trials［J］.Mol Cancer，2023，22（1）：159.
|
| 47 |
Ma C，Yang C，Peng A，et al.Pan-cancer spatially resolved single-cell analysis reveals the crosstalk between cancerassociated fibroblasts and tumor microenvironment［J］.Mol Cancer，2023，22（1）：170.
|